Bayer Schering Pharma AG News

Barr Pharmaceuticals, Inc. has announced that its subsidiary, Barr Laboratories, Inc ., has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application to ... via News-Medical.Net

“We expect to have results of our ongoing Phase IIb trial in the third quarter of this year and look forward to important progress with this program.”

Titan Pharmaceuticals Announces Spheramine Presentation at 76th Annual American Association of Neurological Surgeons Meeting CHICAGO & SOUTH SAN FRANCISCO, Calif.-- --Apr 28, 2008 - Titan Pharmaceuticals, Inc. via Med Ad News

“This news means that many patients with follicular lymphoma will now have access to Zevalin's proven clinical benefits”

The European Commission has extended the marketing authorization for Zevalin in Europe. via Med Ad News

“The CHMP's recommendation represents an important milestone for Zevalin, as it recognizes the potential value that consolidation therapy with Zevalin can offer to patients with follicular lymphoma”

Main Category: Lymphoma / Leukemia Also Included In: Regulatory Affairs / Drug Approvals ; Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 24 Mar 2008 - 0:00 PDT newsletters ... via Medical News Today

“This therapy option will provide clinicians with a treatment regimen that truly could help many of their patients to an extended progression-free survival.”

Bayer Schering Pharma AG has received a positive opinion from the European Committee for Medicinal Products for Human Use recommending Zevalin as consolidation therapy after remission induction in previously ... via Med Ad News